Department of Biochemistry and Molecular Genetics, University of Virginia, 1340 Jefferson Park Ave, P.O. Box 800733, Charlottesville, VA 22908, USA.
Department of Surgery, University of Virginia, Charlottesville, VA 22908, USA.
Epigenetics Chromatin. 2013 Sep 2;6(1):28. doi: 10.1186/1756-8935-6-28.
The epithelial-mesenchymal transition (EMT) is a de-differentiation process required for wound healing and development. In tumors of epithelial origin aberrant induction of EMT contributes to cancer progression and metastasis. Studies have begun to implicate epigenetic reprogramming in EMT; however, the relationship between reprogramming and the coordination of cellular processes is largely unexplored. We have previously developed a system to study EMT in a canonical non-small cell lung cancer (NSCLC) model. In this system we have shown that the induction of EMT results in constitutive NF-κB activity. We hypothesized a role for chromatin remodeling in the sustained deregulation of cellular signaling pathways.
We mapped sixteen histone modifications and two variants for epithelial and mesenchymal states. Combinatorial patterns of epigenetic changes were quantified at gene and enhancer loci. We found a distinct chromatin signature among genes in well-established EMT pathways. Strikingly, these genes are only a small minority of those that are differentially expressed. At putative enhancers of genes with the 'EMT-signature' we observed highly coordinated epigenetic activation or repression. Furthermore, enhancers that are activated are bound by a set of transcription factors that is distinct from those that bind repressed enhancers. Upregulated genes with the 'EMT-signature' are upstream regulators of NF-κB, but are also bound by NF-κB at their promoters and enhancers. These results suggest a chromatin-mediated positive feedback as a likely mechanism for sustained NF-κB activation.
There is highly specific epigenetic regulation at genes and enhancers across several pathways critical to EMT. The sites of these changes in chromatin state implicate several inducible transcription factors with critical roles in EMT (NF-κB, AP-1 and MYC) as targets of this reprogramming. Furthermore, we find evidence that suggests that these transcription factors are in chromatin-mediated transcriptional feedback loops that regulate critical EMT genes. In sum, we establish an important link between chromatin remodeling and shifts in cellular reprogramming.
上皮-间充质转化(EMT)是伤口愈合和发育所必需的去分化过程。在源自上皮的肿瘤中,异常诱导 EMT 有助于癌症进展和转移。研究已经开始暗示表观遗传重编程在 EMT 中的作用;然而,重编程与细胞过程协调之间的关系在很大程度上尚未得到探索。我们之前开发了一种系统来研究经典非小细胞肺癌(NSCLC)模型中的 EMT。在该系统中,我们已经表明 EMT 的诱导导致 NF-κB 活性的组成型。我们假设染色质重塑在细胞信号通路的持续失调中起作用。
我们绘制了十六种组蛋白修饰和两种上皮和间充质状态的变体。在基因和增强子位点定量了组合式表观遗传变化模式。我们在成熟 EMT 途径中的基因中发现了独特的染色质特征。引人注目的是,这些基因只是差异表达基因的一小部分。在具有“EMT-特征”的基因的假定增强子上,我们观察到高度协调的表观遗传激活或抑制。此外,被激活的增强子由一组转录因子结合,这些转录因子与结合被抑制的增强子的转录因子不同。具有“EMT-特征”的上调基因是 NF-κB 的上游调节剂,但也在其启动子和增强子上被 NF-κB 结合。这些结果表明,作为持续 NF-κB 激活的一种可能机制,染色质介导的正反馈可能是一种可能的机制。
在几个关键 EMT 途径的基因和增强子上存在高度特异性的表观遗传调控。染色质状态变化的这些位点暗示了几个可诱导的转录因子(NF-κB、AP-1 和 MYC)作为这种重编程的靶标,在 EMT 中具有关键作用。此外,我们发现的证据表明,这些转录因子存在于调节关键 EMT 基因的染色质介导的转录反馈回路中。总之,我们在染色质重塑和细胞重编程之间建立了重要联系。